In this work, a series of new Nucleoside analogues (D-galactopyranose linked to oxepanebenzimidazole moiety) was synthesized via multisteps synthesis.
Introduction:
Oxepane diones that are heterocyclic compounds with seven-membered oxycyclic are found in a number of natural products such as zoapatanol ,regiolenyne and breveral [1] . Nowaday they have been receiving more attention for their wide range of biomedical applications as cytotoxicity against cancer cell lines, antimicrobial activity and inhibition of several enzyme activities [2] . Also they applied as achemotherapeutic used to treat advanced brain tumors [3] , [4] . On the other hand, benzimidazole has an important chemical entity in pharmaceuticals [5] . Benzimidazole derivatives possess antibacterial effects, antifungal activity, HIV inhibitors, [6] .In another approach nucleoside analogues have found to be important moiety in creation of novel medical compounds. Even though, they have been studied a long time ago, there is still a great potential development of new therapeutic agents as antiviral compounds to treat diseases caused by HIV and hepatitis [7] , antimicrobial agents [8] , anticancer agents [9], [10] .These observations inspire us to synthesis new nucleoside analogues containing oxepane and bezimidazole as a anucleobase and galactose as a asugar moiety which shows good biological activities against three types of bacteria.
Materials and Methods:
Melting points were recorded using Gallenkhamp electro thermal melting point apparatus. FT-IR spectra were recorded on SHIMADZU FT-IR 8400 fourier transform intrared spectrophotometer using KBr disc or thin films. 'H-NMR spectra were recorded on Brukerspectrospin ultra shield magnet 300MHz instrument using Me 4 Si as the internal standard and DMSO-d6 as solvent.TLC plates were used with an aluminum backing (0.2mm, 60 F 254 ), the reactions were monitored by TLC and visualized by development of the TLC plates. Incubator Heraeus D-63450 (Germany) model was used for incubation samples for biological study.
1-Synthesis of 1,2:3,4-di-Oisopropylidene-D-galacto pyranose (1)
Zinc chloride (8.87g, 88mmol) was partially dissolved in (125ml) acetone and (0.4ml) concentrated sulfuric acid was added at room temperature to give a clear solution. (10g, 56mmol) D-galactosewas added in one portion and the resulting white suspension was stirred for 6 hours at room temperature. Asuspension of (20g ,189mmol) sodium carbonate in (30 ml) water added to the yellow reaction mixture at 0° C in medium sized portions. The suspension was allowed to stir for 30 min before filtration and solvent removal in vacuo to give the crude product as tallow oil below the aqueous layer. The organic fraction was separated from the aqueous layer, followed by further extraction with (3x50 ml) diethylether. The organic layer was dried over sodium sulfate [11] , and the solvent removed in vacuo to yield 1,2:3,4-di-O-iso propylidene-Dgalactso (1) as a pale yellow syrup (87%),Rf=0.23 (Et 2 O).
2-Synthesis of 6-Bromo-1,2:3,4di-O-isopropylidene-D-galacto pyransoe(2)
The sugar(1) (20g ,76.9 mmol) was treated with 50% (w/v) hydrogen bromide in acetic acid (52.5 ml). The solution was kept in 0°C unitl TLC in indicated reaction completion (generally within one hour), then poured into an ice-cold chloroform (35 ml) , washed with iced water (3x25 ml) and then with saturated aqueous solution of sodium bicarbonate to remove the remaining acid [12] . After a find wash with iced water (25 ml) the organic phase was dried over anhydrous sodium sulphate to give (2) as syrup (43%) the isolated sugar bromide (2) was used directly for the nucleoside synthesis : Rf 0.43 (Et 2 O: EtOH 1:1), yield 43%.
3-Synthesis of 2-Styryl benzimidazole (3)
Cinnamic acid (2.96 g ,20 mmol) was dissolved in(25 ml) absolute ethanol ,Ophenylenediamine(2.16 g ,20 mmol)was added. The mixturewas refluxed for 12h using water bath. then cooled and poured onto (50ml) ice-cold water 133 containing (1ml) of concentrated HCl,scratched for 15 min, filtered [13] [14] .Dried and recrystallized from ethanol to give (2) as yellow precipitate, yield 75% .
4-Synthesis of benzimidazol-2-yl oxepane-4,7-diones (4-6)
compound (3) (1 mmol) was placed in round bottomed flask; (succinic ,phthalicor maleic) anhydride (1 mmol) in (10 ml) benzene wasadded,then refluxed on water bath for 1 hour the solvent was evaporated and the solid precipitated was recrystalized from tetrahydro furan (THF). Physical properties of compounds (4-6) are listed in Table ( 2).
5-Synthesis of 6-(N-(phenyl oxepane -4,7-dione -3-yl) benzimidazolyl)-1,2,3,-di-Oisopropylidene galactopyranoses (7-9)
(1.08 mmol) isopropylidene sugar bromide (2) was dissolved in (10 ml) of dried xylene, then (0.533 mmol) benzimidazolyl derivatives (4-6) were added and refluxed with vigorous stirring for one hour [12] . TLC (chloroform ether 9:1), the result mixture was cooled to room temperature then filtred and washed with (5 ml) ethanol then dried to give after silica gel column chromatography the protected nucleoside [12] . Physical properties of componneds (7-9) are listed in Table  ( 3).
6-Synthesis of 6-(N-(phenyl oxepane -4,7-dione -3-yl) benzimidazoyl) galactopyranoses (10-12)
A solution of (0.292 mmol) of the protected nucleoside (7-9) in (7 ml) of 0.1 M methanolic sodium methoxide was refluxed with stirring for half hour TLC (chloro form : ethanol 8:2) showed that the reaction was complete. The mixture was neutralized with acetic acid and evaporated to dryness. The residue was partitioned between water and chloroform and the aqueous phase was evaporated to dryness in vacuo. The reside was dissolved in methanol (3 ml) and then chromatographed on a column of silicagel using 9:1 chloroformmethanol as developer [12] . Afforded free nucleoside analogueswas purified by recrystalization from ethanol-ether. Physical properties of compounds (10) (11) (12) are listed in Table (4).
7-Synthesis of 2-(phenyl ethynyl) benzimidazole (13)
The titled compound was prepared by following the same procedure used in preparation of 2cinnamoylbenzimidazole except using of β-phenyl propiolic acid instead of cinnamic acid. The product was purified by recrystallization from elhanol yield 73%.
8-Synthesis of benzimidazolyl -2,3-didehydo oxepane -4,7diones (14-16).
The titled compounds were prepared following the same procedure used in the preparations of compounds (4-6) except using of 2-(phenyl ethynyl) instead of 2-styryl benzimidazole. The final products was purified by recrystallization from tetrahydrofuran (THF) physical properties of compounds (14-16) are listed in Table(9) .
9-Synthesis of 6-(N-(phenyl -2,3didehdro oxepane -4,7 dione -3yl) benzimidazolyl) -1,2,3,4-di-O-isopropylidene galactopyranoses (17-19).
The titled compounds were prepared by following the same procedure used in the preparations of compounds (7-9) except using of benzimidazolyloxcpane 135 -4,7-dions(14-16) instead of compounds (4) (5) (6) . The final products were purified by recrystallization from chloroform physical properties of compounds (17-19) and they are listed in Table (10) .
10-Synthesis of 6-(N-(phenyl -2,3-didehydro oxepane -4,7dione -3-yl) benzimidazolyl) galactopyranoses(20-22)
The titled compounds were prepared following the same procedure used in the preparation of compounds (10-12) using of protected nucleosides (17-19)instead of (7-9). The product was recrystallized from ethanol ether. Physical properties of compounds (20-22) were listed in Table (11) .
11-Microbiological test:
Nutrient agar was added to (1L) of distilled water in suitable conical flask with stirring and heating until complete dissolving then the flask was stoppered by cotton and the medium was sterilized in an autoclave for 20 minutes at (121°) under pressure at 15 pound/inch. The medium was placed in petridishes about (20 ml) for each one and was left to cool and solidified. The studied bacteria and fungi were placed on the nutrient agar surface using the loop and by streaking processor then the discs saturated with tested compound solutions. The samples were incubated for 24 hours at 37°C [15] .
Results and discussion
The synthetic route was started with 2-styrylbenzimidazole (3) and 2-(phenyl ethynyl) benzimidazole (13) which were synthesized from condensation reaction of phenylenediamine withequimolar quantity of cinnamic acid or  -Phenyl propiolic acid respectively via Debus -Radziszewski, reaction. Thesetwocompoundswere reacted with different acid anhydrides (succinic, phthalic, and maleic) to give new substituted oxepanedione derivatives (4-6) and (14-16) subjected to nucleophilic substitution reaction with bromo sugar (2)to give new protected nucleoside analogues (7-9) and (17-19) respectively to obtain our synthetic goal. The free nucleoside analogues play an important role in treatment of tumor cell and as antiviral drugs.Benzimidazole and oxepane (oxepine) ring also have abroad spectrum of biological activities. The overall work steps show in Scheme (1) and Scheme (2) . (13) . FT -IR spectra of (4-6) and (14-16) gave absorption bands at (1685-1693)cm -1 , (1700 -1733) cm -1 attributed to ( C=O) ketone and  (C=O) ester respectively; besides the absence of  (C=O)anhydride at (1800-1840) cm -1 indicated the success of addition reaction of anhydride (4-6) and (14) (15) (16) which subjected to anucleophilic substitution by treating with 6bromo-1,2,3,4-di -Oisopropylidene -Dgalactopyranose (2) in the third step to afford 6 -(N -(phenyl oxepane -4,7dione -3yl) benzimidazolyl) -1,2,3,4. Di -Oisoproplidenegalactopyaroses (7-9) and 6-(N-
Scheme (1):Synthesis of 6-(N-(phenyl oxepane -4,7-dione -3-yl) benzimidazoyl) galactopyranoses (10-12)
TheFT-IR spectrum showed disappearance of bands  (C-Br) , (N-H) benzimidazole with appearance of bands at (1271 -1342)cm -1 attributed to (C-N) nucleoside. 1 H-NMR spectrum of compound (5) , showedsignal at (δ=2.3)ppm belongs to (N-H) proton, signal at (δ=2.74)ppm belongs to (CH-C=O) proton, signal at (δ= 3.6)ppm belongs to (CH-O-C=O) proton, multiplet signals at (δ= 6.5-7.9)ppm belong to aromatic protons , 13 C-NMR showed singletsignal at (δ= 28.74)ppm belongs to (CH-C=O) carbon ,signal at (δ= 39.9)ppm belongs to (CH-CH) carbon ,multiplet signals at (δ=128.12-143.87)ppm belong to aromatic carbon and signal at (δ= 173.56)ppm belong to (C=N) carbon. For synthesis of 6-(N -(phenyl oxepane -4, 7dione -3yl) benzimidazolyl) galactoPyranoses (10-12) and 6-(N-(phenyl -2,3didehydro oxepane -4,7-dione -3-yl) benzimidazolyl) galactopyranoses (20-22) in the fourth step , (7-9) and (17-19) were allowed to hydrolize by methanolic Sodium methoxide at reflux temperature . FT -IR spectrum of (10-12) and (20-22) showed appearance of absorption band at (3350-3357)cm -1 assigned to  (O-H) glycolic and absence of  (C-O-C) ether , other absorption bands to (10) (11) (12) and (20-22) Were (1340) cm -1 , (1579-1580)cm -1 , (1280-1311)cm -1 , (1695-1716)cm -1 due to (C-N) nucleoside, (C=N) imidazole , (C-N) imidazole , (C=O)oxepane respectively. Other details of FT-IR spectral data of the prepared mentioned compounds are listed in Tables (5, 6, 7, 8) and (12, 13, 14) . On the other hand structures of Compound (11) were confirmed also by 1 H-NMR spectrum which showed signal at (δ= 1.9)ppm belong to (CH 2 -NR 2 ) proton signal at (δ= 2.5)ppm belong to (CH-C=O) proton,signal at (δ= 3.6)ppm belong to (CH-O-C=O) proton. 135 13 C-NMRspectrum of compound (11) showed signal at (δ= 28.23)ppm belongs to (CH-C=O) carbon, signal at (δ= 38.91)ppm belongs to (CH 2 -NR 2 ) carbon and signal at (δ= 67.40)ppm belongs to (CH-O-C=O) carbon.
Microbiological test
The prepared nucleosides are screened for their antibacterial activity against three types of bacteria Bacillu, Staphylococcusaureus (gram positive) and E.coli(gram negative) . They showed different biological activities against these bacteria as shown in Table  ( 15) . The result showed a high antibacterial activity of the prepared nucleosidesagaist gram negative more than gram positive, thus compounds (7) (8) (9) (10) (11) (12) ,(17-22) showed highantibacterial activity against E.coli. Also antibacterial activity of the prepared nucleosides depends on nature of substituents in their molecules, thus compounds (17),(18) and (20) which are substituted phenyl ethynyl showed a high antibacterial activity against Staphylococcus aureusalso compounds (8) and (19) have a high antibacterial activity against this bacteria. Other compounds showed a moderate activity against this bacteria. Finally, compounds (7) ,(18) and(21) showed a high antibacterial activity against Bacillus,compounds (9) ,(20) and(22) showed no activity against this bacteria; other compounds showed a moderate activity against this bacteria. 
